medicaid cover semaglutide Rhode Island considers ending coverage of GLP-1 drugs for weight loss • Rhode Island Current Medicaid Coverage of and Spending

Common feedback includes: Relief from Dryness: Users note that their skin feels softer and more hydrated throughout the day, with less tightness and flakiness

Future Directions Important knowledge gaps remain

Variability in Effectiveness : Because compounded medications are custom-made, there can be variability in their dose strengths

Many doctors offices have these products available

Slots, table games, live dealers, and specialty titles serve different moods and budgets

Current Phase 3 trials (expected to report results in 2027) are exploring doses ranging from 4mg to 12mg weekly, with some protocols testing up to 16mg